Medable, developer of a clinical trial platform, has announced the launch of Agent Studio, a new artificial intelligence platform the company says is purpose-built to help life sciences firms use agentic AI.
According to Medable, Agent Studio is a “no-code agent-builder that enables clinical teams to quickly custom-configure AI agents.”
In addition, Medable announced CRA Agent, which the company describes as an “out-of-the-box agent running on Agent Studio” that is custom-made for clinical trial monitoring.
CRA Agent, the first of Medable’s pre-built agents, collects and condenses data across systems, supports human-in-the-loop oversight for crucial areas, and automates regular monitoring and communication.
In a statement, Medable said that Agent Studio allows teams to create “purpose-fit agents that solve key clinical development bottlenecks” that aim to remove white space across intricate trial workflows, including protocol development and trial planning and optimization.
Agent Studio is an extension of Medable’s platform that drives electronic clinical outcome assessment (eCOA), decentralized trial execution and AI-driven study design.
Agent Studio provides advantages including maintaining human-in-the-loop oversight to assure transparency and control; conforming to life sciences standards by integrating standard operation procedures, regulatory and validation needs, and benchmarking against trusted sources; and integrating across life science systems and enterprise platforms including Salesforce, Microsoft and Gmail.
“Agent Studio is more than just technology, it is a catalyst to unleash greater human potential in life sciences,” said Dr. Michelle Longmire, CEO and cofounder of Medable, in a statement. “It frees teams from the bottlenecks of legacy systems, accelerates trials, reduces costs and ultimately helps bring medicines to patients faster.”
THE LARGER TREND
In 2022, Meadable partnered with Withings Health Solutions to use the company’s connected devices for decentralized clinical trials.
The collaboration allowed Withings’ remote monitoring tools, such as connected scales, blood pressure monitors and sleep-tracking mats, to collect patient data and integrate with Medable’s clinical trial platform.
That same year, CVS teamed up with Medable on an initiative to grow clinical trial engagement at the former’s CVS MinuteClinics.
CVS Health Clinical Trial Services ran the effort and uses Medable’s platform to help enroll patients and conduct clinical trials.
The companies pitched the program as a way to help boost diversity in clinical trials by tapping into Medable’s decentralized trial platform and CVS’ geographical reach.
CVS’ trial service, launched in 2021, aimed to work with life science industries to boost research and real-world evidence. The company said that the partnership with Medable helped it continue to develop its efforts in precision patient recruitment, clinical trial delivery and real-world evidence generation.
Source: https://www.mobihealthnews.com/